Cargando…

N-acetylcysteine lacks universal inhibitory activity against influenza A viruses

N-acetylcysteine (NAC) has been recently proposed as an adjuvant therapeutic drug for influenza pneumonia in humans. This proposal is based on its ability to restrict influenza virus replication in vitro and to attenuate the severity of the disease in mouse models. Although available studies were ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Garigliany, Mutien-Marie O, Desmecht, Daniel J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104374/
https://www.ncbi.nlm.nih.gov/pubmed/21554703
http://dx.doi.org/10.1186/1477-5751-10-5

Ejemplares similares